Automated description from the Alliance of Genome Resources
Predicted to have DNA-binding transcription factor activity and enhancer binding activity. Involved in negative regulation of growth; regulation of gene expression; and skeletal system development. Localizes to the nucleus. Used to study Potocki-Lupski syndrome and Smith-Magenis syndrome. Human ortholog(s) of this gene implicated in Smith-Magenis syndrome and intellectual disability. Orthologous to human RAI1 (retinoic acid induced 1).